Based on the process:
The market of global structural cardiovascular devices has been divided into the replacement process and the repair process. The replacement process segment is expected to expand to a high CAGR from 2018 to 2026. The availability of new and innovative devices in the market and transducer is likely to increase the priority for the aortic valve replacement (TAVR) process that the segment will be driven during the forecast period.
In the context of the signal:
The market of global structural cardiovascular devices has been classified into valve stenosis, valve regurgitation, cardiomyopathy, congenital heart defects
Based on the region:
The market of global structural cardiovascular devices has been divided into North America, Latin America, Europe, Asia Pacific and
There are government-friendly policies about health care infrastructure and awareness programs for structural cardiovascular diseases. The Asia Pacific region is expected to grow at a fast pace due to increase in population, change in lifestyle, increase in the number of structural cardiovascular diseases, and per capita health care expenditure. In addition, the growth in economic development and distribution channels supports improvements in health care infrastructure in developing countries like India and China. These factors support the development of the market in Asia Pacific. In the Latin America and Middle East and Africa markets, it is estimated to expand the medium growth rate from 2018 to 2026.